Cargando…
The Impact of the COVID-19 Pandemic on Diagnosing and Treating Attention Deficit Hyperactivity Disorder: New Challenges on Initializing and Optimizing Pharmacological Treatment
INTRODUCTION: COVID-19 has been causing huge disruptions in mental healthcare services worldwide, including those related to ADHD. Some consequences of the pandemic, such as virtual schooling and remote work, as well as increased telemedicine, have posed new challenges for ADHD diagnosis and treatme...
Autor principal: | Segenreich, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020224/ https://www.ncbi.nlm.nih.gov/pubmed/35463503 http://dx.doi.org/10.3389/fpsyt.2022.852664 |
Ejemplares similares
-
Can biomarkers be used to diagnose attention deficit hyperactivity disorder?
por: Chen, Hui, et al.
Publicado: (2023) -
Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
por: Więckiewicz, Gniewko, et al.
Publicado: (2023) -
Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021) -
Attention Deficit Hyperactivity Disorder: Association With Obesity and Eating Disorders
por: Ravi, Prithvi, et al.
Publicado: (2020) -
Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)